Keywords: authorized, generics, increase, competition, following, reports, drug

Authorized generics 'increase competition'

Article | 10 July 2006

Following reports that US drug major Merck & Co had slashed the price of its cholesterol-lowering drug Zocor (simvastatin) to health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in